Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Antihormonal Cancer Therapies Market Size Growth Rate by Type (2014-2025) 1.4.2 Radiations 1.4.3 Drugs 1.4.4 Surgeries 1.4.5 Others 1.5 Market by Application 1.5.1 Global Antihormonal Cancer Therapies Market Share by Application (2019-2025) 1.5.2 Breast Cancer 1.5.3 Prostate Cancer 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Antihormonal Cancer Therapies Market Size 2.2 Antihormonal Cancer Therapies Growth Trends by Regions 2.2.1 Antihormonal Cancer Therapies Market Size by Regions (2019-2025) 2.2.2 Antihormonal Cancer Therapies Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 Antihormonal Cancer Therapies Market Size by by Players 3.1.1 Global Antihormonal Cancer Therapies Revenue by by Players (2014-2019) 3.1.2 Global Antihormonal Cancer Therapies Revenue Market Share by by Players (2014-2019) 3.1.3 Global Antihormonal Cancer Therapies Market Concentration Ratio (CR5 and HHI) 3.2 Antihormonal Cancer Therapies Key Players Head office and Area Served 3.3 Key Players Antihormonal Cancer Therapies Product/Solution/Service 3.4 Date of Enter into Antihormonal Cancer Therapies Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Antihormonal Cancer Therapies Market Size by Type (2014-2019) 4.2 Global Antihormonal Cancer Therapies Market Size by Application (2014-2019) 5 North America 5.1 North America Antihormonal Cancer Therapies Market Size (2014-2019) 5.2 Antihormonal Cancer Therapies Key Players in North America 5.3 North America Antihormonal Cancer Therapies Market Size by Type 5.4 North America Antihormonal Cancer Therapies Market Size by Application 6 Europe 6.1 Europe Antihormonal Cancer Therapies Market Size (2014-2019) 6.2 Antihormonal Cancer Therapies Key Players in Europe 6.3 Europe Antihormonal Cancer Therapies Market Size by Type 6.4 Europe Antihormonal Cancer Therapies Market Size by Application 7 China 7.1 China Antihormonal Cancer Therapies Market Size (2014-2019) 7.2 Antihormonal Cancer Therapies Key Players in China 7.3 China Antihormonal Cancer Therapies Market Size by Type 7.4 China Antihormonal Cancer Therapies Market Size by Application 8 Japan 8.1 Japan Antihormonal Cancer Therapies Market Size (2014-2019) 8.2 Antihormonal Cancer Therapies Key Players in Japan 8.3 Japan Antihormonal Cancer Therapies Market Size by Type 8.4 Japan Antihormonal Cancer Therapies Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Antihormonal Cancer Therapies Market Size (2014-2019) 9.2 Antihormonal Cancer Therapies Key Players in Southeast Asia 9.3 Southeast Asia Antihormonal Cancer Therapies Market Size by Type 9.4 Southeast Asia Antihormonal Cancer Therapies Market Size by Application 10 India 10.1 India Antihormonal Cancer Therapies Market Size (2014-2019) 10.2 Antihormonal Cancer Therapies Key Players in India 10.3 India Antihormonal Cancer Therapies Market Size by Type 10.4 India Antihormonal Cancer Therapies Market Size by Application 11 Central & South America 11.1 Central & South America Antihormonal Cancer Therapies Market Size (2014-2019) 11.2 Antihormonal Cancer Therapies Key Players in Central & South America 11.3 Central & South America Antihormonal Cancer Therapies Market Size by Type 11.4 Central & South America Antihormonal Cancer Therapies Market Size by Application 12 International Players Profiles 12.1 AstraZeneca 12.1.1 AstraZeneca Company Details 12.1.2 Company Description and Business Overview 12.1.3 Antihormonal Cancer Therapies Introduction 12.1.4 AstraZeneca Revenue in Antihormonal Cancer Therapies Business (2014-2019)) 12.1.5 AstraZeneca Recent Development 12.2 Novartis 12.2.1 Novartis Company Details 12.2.2 Company Description and Business Overview 12.2.3 Antihormonal Cancer Therapies Introduction 12.2.4 Novartis Revenue in Antihormonal Cancer Therapies Business (2014-2019) 12.2.5 Novartis Recent Development 12.3 Pfizer 12.3.1 Pfizer Company Details 12.3.2 Company Description and Business Overview 12.3.3 Antihormonal Cancer Therapies Introduction 12.3.4 Pfizer Revenue in Antihormonal Cancer Therapies Business (2014-2019) 12.3.5 Pfizer Recent Development 12.4 Sanofi 12.4.1 Sanofi Company Details 12.4.2 Company Description and Business Overview 12.4.3 Antihormonal Cancer Therapies Introduction 12.4.4 Sanofi Revenue in Antihormonal Cancer Therapies Business (2014-2019) 12.4.5 Sanofi Recent Development 12.5 Takeda 12.5.1 Takeda Company Details 12.5.2 Company Description and Business Overview 12.5.3 Antihormonal Cancer Therapies Introduction 12.5.4 Takeda Revenue in Antihormonal Cancer Therapies Business (2014-2019) 12.5.5 Takeda Recent Development 12.6 Roche 12.6.1 Roche Company Details 12.6.2 Company Description and Business Overview 12.6.3 Antihormonal Cancer Therapies Introduction 12.6.4 Roche Revenue in Antihormonal Cancer Therapies Business (2014-2019) 12.6.5 Roche Recent Development 12.7 Amgen 12.7.1 Amgen Company Details 12.7.2 Company Description and Business Overview 12.7.3 Antihormonal Cancer Therapies Introduction 12.7.4 Amgen Revenue in Antihormonal Cancer Therapies Business (2014-2019) 12.7.5 Amgen Recent Development 12.8 Samyang Biopharmaceuticals 12.8.1 Samyang Biopharmaceuticals Company Details 12.8.2 Company Description and Business Overview 12.8.3 Antihormonal Cancer Therapies Introduction 12.8.4 Samyang Biopharmaceuticals Revenue in Antihormonal Cancer Therapies Business (2014-2019) 12.8.5 Samyang Biopharmaceuticals Recent Development 12.9 Tolmar 12.9.1 Tolmar Company Details 12.9.2 Company Description and Business Overview 12.9.3 Antihormonal Cancer Therapies Introduction 12.9.4 Tolmar Revenue in Antihormonal Cancer Therapies Business (2014-2019) 12.9.5 Tolmar Recent Development 12.10 Bluebird Bio 12.10.1 Bluebird Bio Company Details 12.10.2 Company Description and Business Overview 12.10.3 Antihormonal Cancer Therapies Introduction 12.10.4 Bluebird Bio Revenue in Antihormonal Cancer Therapies Business (2014-2019) 12.10.5 Bluebird Bio Recent Development 12.11 Bristol-Myers Squibb 12.12 Exelixis 12.13 Guardant Health 12.14 Illumina 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Product (2019-2025) 13.2 Market Size Forecast by Application (2019-2025) 13.3 Market Size Forecast by Regions 13.4 North America 13.5 Europe 13.6 China 13.7 Japan 13.8 Southeast Asia 13.9 India 13.10 Central & South America 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Antihormonal Cancer Therapies Key Market Segments Table Key Players Antihormonal Cancer Therapies Covered Table Global Antihormonal Cancer Therapies Market Size Growth Rate by Type 2018-2025 (Million US$) Figuer Radiations Figures Table Key Players of Radiations Figuer Drugs Figures Table Key Players of Drugs Figuer Surgeries Figures Table Key Players of Surgeries Figuer Others Figures Table Key Players of Others Table Global Antihormonal Cancer Therapies Market Size Growth by Application 2019-2025 (Million US$) Figure Global Antihormonal Cancer Therapies Market Share by Application in 2018 & 2025 Figure Breast Cancer Case Studies Figure Prostate Cancer Case Studies Figure Other Case Studies Figure Antihormonal Cancer Therapies Report Years Considered Figure Global Antihormonal Cancer Therapies Market Size and Growth Rate 2014-2025 (Million US$) Table Global Antihormonal Cancer Therapies Market Size by Regions 2019-2025 (Million US$) Table Global Antihormonal Cancer Therapies Market Size by Regions 2019-2025 (Million US$) Table Global Antihormonal Cancer Therapies Market Share by Regions 2014-2019 Figure Global Antihormonal Cancer Therapies Market Share by Regions 2014-2019 Figure Global Antihormonal Cancer Therapies Market Share by Regions in 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global Antihormonal Cancer Therapies Revenue by by Players (2014-2019) (Million US$) Table Global Antihormonal Cancer Therapies Market Share by by Players (2014-2019) Figure Global Antihormonal Cancer Therapies Market Share by by Players in 2018 Table Global Antihormonal Cancer Therapies by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Antihormonal Cancer Therapies Product/Solution/Service Table Date of Enter into Antihormonal Cancer Therapies Market Table Mergers & Acquisitions, Expansion Plans Table Global Antihormonal Cancer Therapies Market Size by Type (2014-2019) (Million US$) Table Global Antihormonal Cancer Therapies Market Size Share by Type (2014-2019) Figure Global Antihormonal Cancer Therapies Market Size Market Share by Type (2014-2019) Table Global Antihormonal Cancer Therapies Market Size by Application (2014-2019) (Million US$) Table Global Antihormonal Cancer Therapies Market Size Share by Application (2014-2019) Figure Global Antihormonal Cancer Therapies Market Size Market Share by Application (2014-2019) Figure Global Antihormonal Cancer Therapies Revenue Market Share by Application in 2018 Figure North America Antihormonal Cancer Therapies Market Size 2014-2019 (Million US$) Table North America Key Players Antihormonal Cancer Therapies Revenue (2018-2019) (Million US$) Table North America Key Players Antihormonal Cancer Therapies Market Share (2018-2019) Table North America Antihormonal Cancer Therapies Market Size by Type 2014-2019 (Million US$) Table North America Antihormonal Cancer Therapies Market Share by Type 2014-2019 Table North America Antihormonal Cancer Therapies Market Size by Application 2014-2019 (Million US$) Table North America Antihormonal Cancer Therapies Market Share by Application 2014-2019 Figure Europe Antihormonal Cancer Therapies Market Size 2014-2019 (Million US$) Table Europe Key Players Antihormonal Cancer Therapies Revenue (2018-2019) (Million US$) Table Europe Key Players Antihormonal Cancer Therapies Market Share (2018-2019) Table Europe Antihormonal Cancer Therapies Market Size by Type 2014-2019 (Million US$) Table Europe Antihormonal Cancer Therapies Market Share by Type 2014-2019 Table Europe Antihormonal Cancer Therapies Market Size by Application 2014-2019 (Million US$) Table Europe Antihormonal Cancer Therapies Market Share by Application 2014-2019 Figure China Antihormonal Cancer Therapies Market Size 2014-2019 (Million US$) Table China Key Players Antihormonal Cancer Therapies Revenue (2018-2019) (Million US$) Table China Key Players Antihormonal Cancer Therapies Market Share (2018-2019) Table China Antihormonal Cancer Therapies Market Size by Type 2014-2019 (Million US$) Table China Antihormonal Cancer Therapies Market Share by Type 2014-2019 Table China Antihormonal Cancer Therapies Market Size by Application 2014-2019 (Million US$) Table China Antihormonal Cancer Therapies Market Share by Application 2014-2019 Figure Japan Antihormonal Cancer Therapies Market Size 2014-2019 (Million US$) Table Japan Key Players Antihormonal Cancer Therapies Revenue (2018-2019) (Million US$) Table Japan Key Players Antihormonal Cancer Therapies Market Share (2018-2019) Table Japan Antihormonal Cancer Therapies Market Size by Type 2014-2019 (Million US$) Table Japan Antihormonal Cancer Therapies Market Share by Type 2014-2019 Table Japan Antihormonal Cancer Therapies Market Size by Application 2014-2019 (Million US$) Table Japan Antihormonal Cancer Therapies Market Share by Application 2014-2019 Figure Southeast Asia Antihormonal Cancer Therapies Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Antihormonal Cancer Therapies Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Antihormonal Cancer Therapies Market Share (2018-2019) Table Southeast Asia Antihormonal Cancer Therapies Market Size by Type 2014-2019 (Million US$) Table Southeast Asia Antihormonal Cancer Therapies Market Share by Type 2014-2019 Table Southeast Asia Antihormonal Cancer Therapies Market Size by Application 2014-2019 (Million US$) Table Southeast Asia Antihormonal Cancer Therapies Market Share by Application 2014-2019 Figure India Antihormonal Cancer Therapies Market Size 2014-2019 (Million US$) Table India Key Players Antihormonal Cancer Therapies Revenue (2018-2019) (Million US$) Table India Key Players Antihormonal Cancer Therapies Market Share (2018-2019) Table India Antihormonal Cancer Therapies Market Size by Type 2014-2019 (Million US$) Table India Antihormonal Cancer Therapies Market Share by Type 2014-2019 Table India Antihormonal Cancer Therapies Market Size by Application 2014-2019 (Million US$) Table India Antihormonal Cancer Therapies Market Share by Application 2014-2019 Figure Central & South America Antihormonal Cancer Therapies Market Size 2014-2019 (Million US$) Table Central & South America Key Players Antihormonal Cancer Therapies Revenue (2018-2019) (Million US$) Table Central & South America Key Players Antihormonal Cancer Therapies Market Share (2018-2019) Table Central & South America Antihormonal Cancer Therapies Market Size by Type 2014-2019 (Million US$) Table Central & South America Antihormonal Cancer Therapies Market Share by Type 2014-2019 Table Central & South America Antihormonal Cancer Therapies Market Size by Application 2014-2019 (Million US$) Table Central & South America Antihormonal Cancer Therapies Market Share by Application 2014-2019 Table AstraZeneca Company Details Table AstraZeneca Revenue in Antihormonal Cancer Therapies Business 2014-2019 (Million US$) Figure AstraZeneca Revenue Growth Rate in Antihormonal Cancer Therapies Business (2014-2019) Table AstraZeneca Recent Development Table Novartis Company Details Table Novartis Revenue in Antihormonal Cancer Therapies Business 2014-2019 (Million US$) Figure Novartis Revenue Growth Rate in Antihormonal Cancer Therapies Business (2014-2019) Table Novartis Recent Development Table Pfizer Company Details Table Pfizer Revenue in Antihormonal Cancer Therapies Business 2014-2019 (Million US$) Figure Pfizer Revenue Growth Rate in Antihormonal Cancer Therapies Business (2014-2019) Table Pfizer Recent Development Table Sanofi Company Details Table Sanofi Revenue in Antihormonal Cancer Therapies Business 2014-2019 (Million US$) Figure Sanofi Revenue Growth Rate in Antihormonal Cancer Therapies Business (2014-2019) Table Sanofi Recent Development Table Takeda Company Details Table Takeda Revenue in Antihormonal Cancer Therapies Business 2014-2019 (Million US$) Figure Takeda Revenue Growth Rate in Antihormonal Cancer Therapies Business (2014-2019) Table Takeda Recent Development Table Roche Company Details Table Roche Revenue in Antihormonal Cancer Therapies Business 2014-2019 (Million US$) Figure Roche Revenue Growth Rate in Antihormonal Cancer Therapies Business (2014-2019) Table Roche Recent Development Table Amgen Company Details Table Amgen Revenue in Antihormonal Cancer Therapies Business 2014-2019 (Million US$) Figure Amgen Revenue Growth Rate in Antihormonal Cancer Therapies Business (2014-2019) Table Amgen Recent Development Table Samyang Biopharmaceuticals Company Details Table Samyang Biopharmaceuticals Revenue in Antihormonal Cancer Therapies Business 2014-2019 (Million US$) Figure Samyang Biopharmaceuticals Revenue Growth Rate in Antihormonal Cancer Therapies Business (2014-2019) Table Samyang Biopharmaceuticals Recent Development Table Tolmar Company Details Table Tolmar Revenue in Antihormonal Cancer Therapies Business 2014-2019 (Million US$) Figure Tolmar Revenue Growth Rate in Antihormonal Cancer Therapies Business (2014-2019) Table Tolmar Recent Development Table Bluebird Bio Company Details Table Bluebird Bio Revenue in Antihormonal Cancer Therapies Business 2014-2019 (Million US$) Figure Bluebird Bio Revenue Growth Rate in Antihormonal Cancer Therapies Business (2014-2019) Table Bluebird Bio Recent Development Table Bristol-Myers Squibb Company Details Table Exelixis Company Details Table Guardant Health Company Details Table Illumina Company Details Table Global Antihormonal Cancer Therapies Market Size by Regions (Million US$) 2019-2025 Figure Global Antihormonal Cancer Therapies Market Size Share by Regions (2019-2025) Figure Global Antihormonal Cancer Therapies Market Size Share by Regions in 2025 Figure North America Antihormonal Cancer Therapies Market Size Forecast (2019-2025)(Million USD) Figure Europe Antihormonal Cancer Therapies Market Size Forecast (2019-2025)(Million USD) Figure China Antihormonal Cancer Therapies Market Size Forecast (2019-2025)(Million USD) Figure Japan Antihormonal Cancer Therapies Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Antihormonal Cancer Therapies Market Size Forecast (2019-2025)(Million USD) Figure India Antihormonal Cancer Therapies Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Antihormonal Cancer Therapies Market Size Forecast (2019-2025)(Million USD) Table Global Antihormonal Cancer Therapies Market Size by Product (2019-2025) (Million US$) Figure Global Antihormonal Cancer Therapies Market Size by Product (2019-2025) Figure Global Antihormonal Cancer Therapies Market Size by Product in 2025 Table Global Antihormonal Cancer Therapies Market Size by Application (2019-2025) (Million US$) Figure Global Antihormonal Cancer Therapies Market Size by Application (2019-2025) Figure Global Antihormonal Cancer Therapies Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

AstraZeneca Novartis Pfizer Sanofi Takeda Roche Amgen Samyang Biopharmaceuticals Tolmar Bluebird Bio Bristol-Myers Squibb Exelixis Guardant Health Illumina